Dataset Information

Superior Frontal Gyrus TOMM40-APOE Locus DNA Methylation in Alzheimer's Disease.

ABSTRACT:

Background

The APOE ɛ4 allele is the strongest known genetic risk factor for sporadic Alzheimer's disease (AD). The neighboring TOMM40 gene has also been implicated in AD due to its close proximity to APOE.

Objective

Here we tested whether methylation of the TOMM40-APOE locus may influence ApoE protein levels and AD pathology.

Methods

DNA methylation levels across the TOMM40-APOE locus and ApoE levels were measured in superior frontal gyrus tissues of 62 human brains genotyped for APOE and scored for AD neuropathology.

Results

Methylation levels within the TOMM40 CpG island in the promoter or APOE CpG island in Exon 4 did not differ between APOE ɛ4 carriers versus non-carriers. However, APOE ɛ4 carriers had significantly higher methylation the APOE promoter compared with non-carriers. Although DNA methylation at TOMM40, APOE promoter region, or APOE did not differ between AD pathological groups, there was a negative association between TOMM40 methylation and CERAD scores. ApoE protein concentrations did not significantly different between APOE ɛ4 carriers and non-carriers, or between AD pathological groups. Finally, there was no correlation between ApoE protein concentrations and DNA methylation levels.

Conclusion

APOE gene methylation may not be affected by genotype, relate to AD pathology or ApoE protein levels in the superior frontal gyrus, though, DNA methylation at the ApoE promoter differed between genotype. DNA methylation at TOMM40 associated with amyloid-β plaques and longitudinal fluid intelligence. In sum, these results suggest a complicated regulation of the TOMM40-APOE locus in the brain in controlling ApoE protein levels and AD neuropathology.

SUBMITTER: Bezuch N

PROVIDER: S-EPMC8150259 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Superior Frontal Gyrus <i>TOMM40-APOE</i> Locus DNA Methylation in Alzheimer's Disease.

Bezuch Natalia N Bradburn Steven S Robinson Andrew C AC Pendleton Neil N Payton Antony A Murgatroyd Chris C

Journal of Alzheimer's disease reports 20210406 1

<h4>Background</h4>The <i>APOE</i> ɛ4 allele is the strongest known genetic risk factor for sporadic Alzheimer's disease (AD). The neighboring <i>TOMM40</i> gene has also been implicated in AD due to its close proximity to <i>APOE</i>.<h4>Objective</h4>Here we tested whether methylation of the <i>TOMM40-APOE</i> locus may influence ApoE protein levels and AD pathology.<h4>Methods</h4>DNA methylation levels across the <i>TOMM40-APOE</i> locus and ApoE levels were measured in superior frontal gyru ...[more]

PMID: 34113784

Similar Datasets

Project description:BackgroundAlzheimer's disease affects ~13% of people in the United States 65 years and older, making it the most common neurodegenerative disorder. Recent work has identified roles for environmental, genetic, and epigenetic factors in Alzheimer's disease risk.MethodsWe performed a genome-wide screen of DNA methylation using the Illumina Infinium HumanMethylation450 platform on bulk tissue samples from the superior temporal gyrus of patients with Alzheimer's disease and non-demented controls. We paired a sliding window approach with multivariate linear regression to characterize Alzheimer's disease-associated differentially methylated regions (DMRs).ResultsWe identified 479 DMRs exhibiting a strong bias for hypermethylated changes, a subset of which were independently associated with aging. DMR intervals overlapped 475 RefSeq genes enriched for gene ontology categories with relevant roles in neuron function and development, as well as cellular metabolism, and included genes reported in Alzheimer's disease genome-wide and epigenome-wide association studies. DMRs were enriched for brain-specific histone signatures and for binding motifs of transcription factors with roles in the brain and Alzheimer's disease pathology. Notably, hypermethylated DMRs preferentially overlapped poised promoter regions, marked by H3K27me3 and H3K4me3, previously shown to co-localize with aging-associated hypermethylation. Finally, the integration of DMR-associated single nucleotide polymorphisms with Alzheimer's disease genome-wide association study risk loci and brain expression quantitative trait loci highlights multiple potential DMRs of interest for further functional analysis.ConclusionWe have characterized changes in DNA methylation in the superior temporal gyrus of patients with Alzheimer's disease, highlighting novel loci that facilitate better characterization of pathways and mechanisms underlying Alzheimer's disease pathogenesis, and improve our understanding of epigenetic signatures that may contribute to the development of disease.